Concepedia

Eric S. Fischer

ES

Statistics

Publications

119

Citations

13.6K

H-Index

56

Active since

1949

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Broad Institute

Stanford University

Brigham and Women's Hospital

Eric S. Fischer is an author at Dana-Farber Cancer Institute specializing in molecular biology, life sciences, and molecular oncology.

ORCID

Publications per year

1949–2025

119

Publications

119

Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide

Eric S. Fischer, Kerstin Böhm, John R. Lydeard et al. · Nature · 2014 · 1.1K citations · Full text

, , +9

Plasticity in binding confers selectivity in ligand-induced protein degradation

Radosław P. Nowak, Stephen L. DeAngelo, Dennis L. Buckley et al. · Nature Chemical Biology · 2018 · 631 citations

, , +14

Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase

Georg Petzold, Eric S. Fischer, Nicolas H. Thomä · Nature · 2016 · 605 citations · Full text

, , +12

Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

Baishan Jiang, Michael A. Erb, Yanke Liang et al. · Nature Chemical Biology · 2017 · 550 citations · Full text

, , +8

Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome

Katherine A. Donovan, An Jian, Radosław P. Nowak et al. · eLife · 2018 · 517 citations · Full text

, , +13

1–5 of 119